Assay of insulin mediator activity with soluble pyruvate dehydrogenase phosphatase
- PMID: 2985364
- DOI: 10.1210/endo-116-5-1912
Assay of insulin mediator activity with soluble pyruvate dehydrogenase phosphatase
Abstract
The putative mediator of intracellular insulin action has been assayed quantitatively by its ability to increase the activity of solubilized pyruvate dehydrogenase (PDH) phosphatase. Conversion of soluble beef heart PDH b to PDH a by PDH phosphatase increased when incubation was carried out in the presence of a crude insulin mediator fraction generated from insulin-treated adipose tissue or liver plasma membranes. Increased PDH phosphatase activity was proportional to the concentration of added insulin mediator. Mediator generation was rapid, with a half-time of approximately 45 sec and was insulin dose dependent. Half-maximal mediator activity was produced at 0.3 nM added insulin, with maximal activity being generated at approximately 3 nM insulin. Mediator activity was significantly decreased at 7 nM insulin, but was increased 4-fold after ethanol extraction. Mediator behaved as an activator of PDH phosphatase, apparently by abolishing the inhibitory effects of ATP on phosphatase activity, but had no effect on PDH kinase activity. The assay of insulin mediator activity described here can be carried out under standardized conditions, in contrast to previously described methods using particulate mitochondrial preparations.
Similar articles
-
Insulin mediator stimulation of pyruvate dehydrogenase phosphatases.Arch Biochem Biophys. 1992 Jul;296(1):170-4. doi: 10.1016/0003-9861(92)90559-f. Arch Biochem Biophys. 1992. PMID: 1318688
-
Insulin mediator causes dephosphorylation of the alpha subunit of pyruvate dehydrogenase by stimulating phosphatase activity.Arch Biochem Biophys. 1985 Feb 15;237(1):142-50. doi: 10.1016/0003-9861(85)90263-2. Arch Biochem Biophys. 1985. PMID: 2982326
-
Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphatase.J Clin Endocrinol Metab. 1996 Mar;81(3):1051-7. doi: 10.1210/jcem.81.3.8772575. J Clin Endocrinol Metab. 1996. PMID: 8772575
-
Lipoyl-containing components of the pyruvate dehydrogenase complex: roles in modulating and anchoring the PDH kinase and the PDH phosphatase.Ann N Y Acad Sci. 1989;573:168-74. doi: 10.1111/j.1749-6632.1989.tb14994.x. Ann N Y Acad Sci. 1989. PMID: 2561315 Review. No abstract available.
-
Regulation of pyruvate dehydrogenase by insulin action.Prog Clin Biol Res. 1979;31:707-19. Prog Clin Biol Res. 1979. PMID: 231784 Review.
Cited by
-
Reciprocal control of pyruvate dehydrogenase kinase and phosphatase by inositol phosphoglycans. Dynamic state set by "push-pull" system.J Biol Chem. 2008 Nov 28;283(48):33428-36. doi: 10.1074/jbc.M801781200. Epub 2008 Sep 3. J Biol Chem. 2008. PMID: 18768479 Free PMC article.
-
Insulin regulation of the activity and phosphorylation of branched-chain 2-oxo acid dehydrogenase in adipose tissue.Biochem J. 1989 Feb 15;258(1):229-35. doi: 10.1042/bj2580229. Biochem J. 1989. PMID: 2649086 Free PMC article.
-
Inhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy.Antioxidants (Basel). 2023 Mar 20;12(3):756. doi: 10.3390/antiox12030756. Antioxidants (Basel). 2023. PMID: 36979003 Free PMC article. Review.
-
Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells.Proc Natl Acad Sci U S A. 1990 Feb;87(4):1476-80. doi: 10.1073/pnas.87.4.1476. Proc Natl Acad Sci U S A. 1990. PMID: 2137614 Free PMC article.
-
The biological activity of structurally defined inositol glycans.Future Med Chem. 2009 Apr;1(1):95-118. doi: 10.4155/fmc.09.6. Future Med Chem. 2009. PMID: 20390053 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources